EW today
$105.80-$0.01 (-0.01%)close Nov 12, 2026Trend
DailyUptrend (starting)
4 hourStrong Bullish
1 hourLeaning Bearish
15 minLeaning Bullish
5 minBearish
Daily trend turns down below $58.93
Key levels
Resistance$113.40
Resistance$108.83
Support$105.79
Support$101.24
Latest news & SEC filings
AnalystTD Cowen keeps Buy rating on Edwards Lifesciences, lifts target to $121
SEC FilingEdwards Lifesciences Corp filed an insider trading report (Form 4)
All EW news →About Edwards Lifesciences
Edwards Lifesciences develops medical devices for structural heart disease. Its main product groups are transcatheter aortic valve replacement, transcatheter mitral and tricuspid therapies, and surgical structural heart devices, including tissue heart valves and repair rings. It sells to hospitals, physicians, and healthcare systems through direct sales teams and independent distributors, operating in roughly 100 countries across the United States, Europe, Japan, and other regions.
Based on the company's 10-K filed Feb 25, 2026.
NYSE · Healthcare
Edwards Lifesciences Corp (EW)
What Is the Price Target for EW?
SEPT Low Target
$85.00
SEPT Mid Target
$114.00
SEPT High Target
$121.00
Analyst Consensus
$114.00
Is EW a Buy or Sell Right Now?
Thesis
- •Revenue growing 11.6% YoY with STABLE trend — consistent growth.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for EW.
Start Free Trial →Is EW Overvalued or Undervalued?
Valuation Verdict
OVERVALUED
Methods Used
P/E Forward, P/B, Analyst Consensus
Fair Value
$92.64
55
Moat Score
NARROW
5/9
Piotroski Score
13.6
Altman Z-Score
What Is Smart Money Doing with EW?
Insider Signal
SELLING
0 buys / 11 sells (90d)
Congress Signal
BUYING
4 buys / 3 sells (90d)
Institutional
N/A
Short Squeeze Risk
LOW
Signal: NEUTRAL
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Lippis Daniel J. | officer | Buy | 619 | $45K | Nov 10, 2026 |
| Lippis Daniel J. | officer | Sale | 619 | $65K | Nov 10, 2026 |
| Lippis Daniel J. | officer | Buy | 619 | $45K | Oct 8, 2026 |
| Lippis Daniel J. | officer | Sale | 619 | $53K | Oct 8, 2026 |
| Chopra Daveen | officer | Sale | 398 | $35K | Sep 11, 2026 |
| Lippis Daniel J. | officer | Buy | 619 | $45K | Sep 11, 2026 |
| Lippis Daniel J. | officer | Sale | 619 | $54K | Sep 11, 2026 |
| Dahl Andrew M. | officer | Sale | 544 | $50K | Aug 31, 2026 |
| Bruls Annette | officer | Sale | 2,644 | $238K | Aug 28, 2026 |
| Zovighian Bernard J | director officer | Sale | 319 | - | Jul 27, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →EW Growth Story
Revenue YoY
11.6%
3yr Revenue CAGR
10.8%
EPS Growth YoY
-73.74%
FCF Growth YoY
37.1%
Revenue Trend
STABLE
Dark Pool Trades for EW
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for EW, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 22:25:08 | $105.81 | 20,643 | $$2.2M | BUY |
| 21:43:41 | $105.81 | 16,933 | $$1.8M | BUY |
| 21:28:25 | $105.81 | 8,991 | $$951K | BUY |
| 21:00:33 | $105.81 | 1,782 | $$189K | BUY |
| 21:00:33 | $105.81 | 4,100 | $$434K | BUY |
5 dark pool trades shown · $$5.5M preview volume
Real-time institutional flow, block trades, and net positioning
Options Flow for EW
PREVIEWSEPT Investing provides real-time options flow tracking for EW, including unusual sweep detection, block trades, and dealer positioning. Each trade shows strike, expiry, premium, implied volatility, and greek values for informed decision-making.
| Type | Strike | Expiry | DTE | Premium | Size | Trade |
|---|---|---|---|---|---|---|
| CALL | $105 | Dec 18 | 37 | $$340 | 1 | SWEEP |
| CALL | $105 | Dec 18 | 37 | $$660 | 2 | SWEEP |
| CALL | $105 | Dec 18 | 37 | $$330 | 1 | SWEEP |
| CALL | $105 | Dec 18 | 37 | $$330 | 1 | SWEEP |
| CALL | $105 | Dec 18 | 37 | $$330 | 1 | SWEEP |
5 options trades shown · 100% calls
Unusual activity, GEX levels, max pain, and dealer positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Edwards Lifesciences Corp (EW) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →EW — frequently asked questions
What is EW stock price today?
Edwards Lifesciences Corp (EW) is at $105.80, down 0.01% (-$0.01) at the Nov 12, 2026 close.
Why is EW stock moving today?
Latest EW news — Nov 11, 2026: TD Cowen keeps Buy rating on Edwards Lifesciences, lifts target to $121 · Nov 10, 2026: Edwards Lifesciences Corp filed an insider trading report (Form 4)
Why did EW stock move on Nov 4, 2026?
Edwards Lifesciences reported third-quarter adjusted EPS of $0.80 and sales of $1.716 billion, both above analyst estimates, while also lifting its full-year 2026 adjusted EPS outlook to $2.97-$3.05. However, the company's fourth-quarter guidance of $0.61-$0.69 per share and $1.670-$1.750 billion in sales fell short of analyst estimates, and it narrowed its FY2026 sales guidance to $6.766 billion.
What is the EW price target?
The average analyst price target for EW is $114.00, ranging from $85 to $121, based on 16 analysts. Latest: TD Cowen maintains on Nov 11, 2026.
What do analysts rate EW?
Analyst ratings for EW: 3 Buy, 29 Hold, 0 Sell — consensus Hold.
Did EW beat earnings?
EW last reported on Nov 4, 2026: EPS $0.80 vs $0.74 expected — a beat of 8.5%.
What is EW's P/E ratio?
EW trades at a P/E of 58.8 vs a Healthcare average of 17.2.
Does EW pay a dividend?
EW does not currently pay a dividend.
What are EW support and resistance levels?
Support: $105.79, $101.24, $96.29. Resistance: $108.83, $113.40, $118.56.
What are insiders doing with EW?
Insider activity: SELLING, 0 buys and 11 sells in the last 90 days.
What is the latest news on EW?
Nov 11, 2026: TD Cowen keeps Buy rating on Edwards Lifesciences, lifts target to $121 · Nov 10, 2026: Edwards Lifesciences Corp filed an insider trading report (Form 4)